The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: tenofovir     Quarter: 2016Q3

Total Records: 439     Number of Pages: 22

DRUGNAME PT EventCount
TENOFOVIR DISOPROXIL FUMARATE. Asthenia 2
TENOFOVIR DISOPROXIL FUMARATE. Atrial fibrillation 2
TENOFOVIR DISOPROXIL FUMARATE. Atrial septal defect 2
TENOFOVIR DISOPROXIL FUMARATE. Autoimmune hepatitis 2
TENOFOVIR DISOPROXIL FUMARATE. Blood creatinine increased 2
TENOFOVIR DISOPROXIL FUMARATE. Blood phosphorus decreased 2
TENOFOVIR DISOPROXIL FUMARATE. Congenital choroid plexus cyst 2
TENOFOVIR DISOPROXIL FUMARATE. Contraindication to medical treatment 2
TENOFOVIR DISOPROXIL FUMARATE. Creatinine renal clearance decreased 2
TENOFOVIR DISOPROXIL FUMARATE. Diplopia 2
TENOFOVIR DISOPROXIL FUMARATE. Drug interaction 2
TENOFOVIR DISOPROXIL FUMARATE. Drug-induced liver injury 2
TENOFOVIR DISOPROXIL FUMARATE. Eyelid ptosis 2
TENOFOVIR DISOPROXIL FUMARATE. Fall 2
TENOFOVIR DISOPROXIL FUMARATE. Fistula 2
TENOFOVIR DISOPROXIL FUMARATE. Gastrointestinal haemorrhage 2
TENOFOVIR DISOPROXIL FUMARATE. Hypokalaemia 2
TENOFOVIR DISOPROXIL FUMARATE. Hypophagia 2
TENOFOVIR DISOPROXIL FUMARATE. Immune reconstitution inflammatory syndrome 2
TENOFOVIR DISOPROXIL FUMARATE. Irritability 2

Total Records: 439     Number of Pages: 22